miRNAs at the heart of the matter

Journal of Molecular Medicine

Volumn 86, Issue 7, 2008, Pages 771-783

  Wang, Zhiguo ^a,b,c   Luo, Xioabin ^a,b   Lu, Yanjie ^c   Yang, Baofeng ^c  

^a MONTREAL HEART INSTITUTE   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Arrhythmias; Heart; Hypertrophy; miRNA; miRNA mask; miRNA mimic

Indexed keywords

CONNEXIN 43; DICER; ENDOTHELIAL NITRIC OXIDE SYNTHASE; HEAT SHOCK PROTEIN 60; HEAT SHOCK PROTEIN 70; INTERLEUKIN 8; MICRORNA; POTASSIUM CHANNEL KCNE1; POTASSIUM CHANNEL KCNQ1; PROTEIN BCL 2; PROTEIN KINASE B; SHAL POTASSIUM CHANNEL; SOMATOMEDIN C; TIE 1 RECEPTOR; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR E2F; TRANSCRIPTION FACTOR ERG; TRANSCRIPTION FACTOR IRX5; TRANSCRIPTION FACTOR SP1; TRANSFORMING GROWTH FACTOR BETA;

ANGIOGENESIS; AORTA STENOSIS; APOPTOSIS; ARRHYTHMOGENESIS; CARDIOVASCULAR DISEASE; DEVELOPED COUNTRY; GENE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; GENE TARGETING; GENETIC STABILITY; GJA1 GENE; HCN2 GENE; HCN4 GENE; HEART FAILURE; HEART FUNCTION; HEART HYPERTROPHY; HEART INFARCTION; HEART MUSCLE CELL; HUMAN; HYPERTENSION; KCNJ2 GENE; MORBIDITY; MORTALITY; NONHUMAN; REVIEW; RNA INTERFERENCE; SIGNAL TRANSDUCTION; VALVULAR HEART DISEASE;

APOPTOSIS; ARRHYTHMIAS, CARDIAC; CARDIOMEGALY; HEART DISEASES; HEART FAILURE; HUMANS; MICRORNAS; MODELS, BIOLOGICAL; MYOCARDIUM;

EID: 46149090813     PISSN: 09462716     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00109-008-0341-3     Document Type: Review

References (76)

1. Latronico MVG, Catalucci D, Condorelli G (2007) Emerging role of microRNAs in cardiovascular biology. Circ Res 101:1225-1236
2. Callis TE, Chen JF, Wang DZ (2007) MicroRNAs in skeletal and cardiac muscle development. DNA Cell Biol 26:219-225
3. van Rooij E, Olson EN (2007) MicroRNAs: powerful new regulators of heart disease and provocative therapeutic targets. J Clin Invest 117:2369-2376
4. Chien KR (2007) MicroRNAs and the tell-tale heart. Nature 447:389-390
5. Anderson ME, Mohler PJ (2007) Micro RNA may have macro effect on sudden death. Nat Med 13:410-411
6. Mishima Y, Stahlhut C, Giraldez AJ (2007) miR-1-2 gets to the heart of the matter. Cell 129:248-249
7. Lee Y, Kim M, Han J, Yeom KH, Lee S, Baek SH, Kim VN (2004) MicroRNA genes are transcribed by RNA polymerase II. EMBO J 23:4051-4060
8. Lee Y, Jeon K, Lee JT, Kim S, Kim VN (2002) MicroRNA maturation: stepwise processing and subcellular localization. EMBO J 21:4663-4670
9. Kim VN (2004) MicroRNA precursors in motion: exportin-5 mediates their nuclear export. Trends Cell Biol 14:156-159
10. Peters L, Meister G (2007) Argonaute proteins: mediators of RNA silencing. Mol Cell 26:611-623
11. Liu J, Valencia-Sanchez MA, Hannon GJ, Parker R (2005) MicroRNA-dependent localization of targeted mRNAs to mammalian P-bodies. Nat Cell Biol 7:719-723
12. Brennecke J, Stark A, Russell RB, Cohen SM (2005) Principles of microRNA-target recognition. PLoS Biol 3:404-418
13. Jackson RJ, Standart N (2007) How do microRNAs regulate gene expression? Sci STKE 23:243-249
14. Lewis BP, Shih I-H, Jones-Rhoades MW, Bartel DP, Burge CB (2003) Prediction of mammalian microRNA targets. Cell 115:787-798
15. Nilsen TW (2007) Mechanisms of microRNA-mediated gene regulation in animal cells. Trends Genet 23:243-249
16. Pillai RS, Bhattacharyya SN, Filipowicz W (2007) Repression of protein synthesis by miRNAs: how many mechanisms? Trends Cell Biol 17:118-126
17. Zhao Y, Samal E, Srivastava D (2005) Serum response factor regulates a muscle-specific microRNA that targets Hand2 during cardiogenesis. Nature 436:214-220
18. Vasudevan S, Tong Y, Steitz JA (2007) Switching from repression to activation: microRNAs can up-regulate translation. Science 318:1931-1934
19. Lim LP, Lau NC, Garrett-Engele P, Grimson A, Schelter JM, Castle J, Bartel DP, Linsley PS, Johnson JM (2005) Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature 433:769-773
20. Alvarez-Garcia I, Miska EA (2005) MicroRNA functions in animal development and human disease. Development 132:4653-4662
21. Ambros V (2004) The functions of animal microRNAs. Nature 431:350-355
22. Lewis BP, Burge CB, Bartel DP (2005) Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120:15-20
23. Miranda KC, Huynh T, Tay Y, Ang YS, Tam WL, Thomson AM, Lim B, Rigoutsos I (2006) A pattern-based method for the identification of MicroRNA binding sites and their corresponding heteroduplexes. Cell 126:1203-1217
24. Lagos-Quintana M, Rauhut R, Yalcin A, Meyer J, Lendeckel W, Tuschl T (2002) Identification of tissue-specific miRNAs from mouse. Curr Biol 12:735-739
25. Ji R, Cheng Y, Yue J, Yang J, Liu X, Chen H, Dean DB, Zhang C (2007) MicroRNA expression signature and antisense-mediated depletion reveal an essential role of MicroRNA in vascular neointimal lesion formation. Circ Res 100:1579-1588
26. Chen JF, Mandel EM, Thomson JM, Wu Q, Callis TE, Hammond SM, Conlon FL, Wang DZ (2006) The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation. Nat Genet 38:228-233
27. Rao PK, Kumar RM, Farkhondeh M, Baskerville S, Lodish HF (2006) Myogenic factors that regulate expression of muscle-specific microRNAs. Proc Natl Acad Sci U S A 103:8721-8726
28. Kwon C, Han Z, Olson EN, Srivastava D (2005) MicroRNA1 influences cardiac differentiation in Drosophila and regulates Notch signaling. Proc Natl Acad Sci U S A 102:18986-18991
29. Zhao Y, Ransom JF, Li A, Vedantham V, von Drehle M, Muth AN, Tsuchihashi T, McManus MT, Schwartz RJ, Srivastava D (2007) Dysregulation of cardiogenesis, cardiac conduction, and cell cycle in mice lacking miRNA-1-2. Cell 129:303-317
30. Sokol NS, Ambros V (2005) Mesodermally expressed Drosophila microRNA-1 is regulated by Twist and is required in muscles during larval growth. Genes Dev 19:2343-2354
31. Wienholds E, Kloosterman WP, Miska E, Alvarez-Saavedra E, Berezikov E, de Bruijn E, Horvitz HR, Kauppinen S, Plasterk RH (2005) MicroRNA expression in zebrafish embryonic development. Science 309:310-311
32. van Rooij E, Sutherland LB, Qi X, Richardson JA, Hill J, Olson EN (2007) Control of stress-dependent cardiac growth and gene expression by a microRNA. Science 316:575-579
33. Niu Z, Li A, Zhang SX, Schwartz RJ (2007) (2007) Serum response factor micromanaging cardiogenesis. Curr Opin Cell Biol 19:918-627
34. Liu N, Williams AH, Kim Y, McAnally J, Bezprozvannaya S, Sutherland LB, Richardson JA, Bassel-Duby R, Olson EN (2007) An intragenic MEF2-dependent enhancer directs muscle-specific expression of microRNAs 1 and 133. Proc Natl Acad Sci U S A 104:20844-20849
35. Giraldez AJ, Cinalli RM, Glasner ME, Enright AJ, Thomson JM, Baskerville S, Hammond SM, Bartel DP, Schier AF (2005) MicroRNAs regulate brain morphogenesis in zebrafish. Science 308:833-838
36. Srivastava D, Thomas T, Lin Q, Kirby ML, Brown D, Olson EN (1997) Regulation of cardiac mesodermal and neural crest development by the bHLH transcription factor, dHAND. Nat Genet 16:154-160
37. McKinsey TA, Olson EN (2005) Toward transcriptional therapies for the failing heart: chemical screens to modulate genes. J Clin Invest 115:538-546
38. van Rooij E, Sutherland LB, Liu N, Williams AH, McAnally J, Gerard RD, Richardson JA, Olson EN (2006) A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure. Proc Natl Acad Sci U S A 103:18255-18260
39. Sayed D, Hong C, Chen IY, Lypowy J, Abdellatif M (2007) MicroRNAs play an essential role in the development of cardiac hypertrophy. Circ Res 100:416-424
40. Carè A, Catalucci D, Felicetti F, Bonci D, Addario A, Gallo P, Bang ML, Segnalini P, Gu Y, Dalton ND, Elia L, Latronico MV, Høydal M, Autore C, Russo MA, Dorn GW, Ellingsen O, Ruiz-Lozano P, Peterson KL, Croce CM, Peschle C, Condorelli G (2007) MicroRNA-133 controls cardiac hypertrophy. Nat Med 13:613-618
41. Cheng Y, Ji R, Yue J, Yang J, Liu X, Chen H, Dean DB, Zhang C (2007) MicroRNAs are aberrantly expressed in hypertrophic heart. Do they play a role in cardiac hypertrophy? Am J Pathol 170:1831-1840
42. Tatsuguchi M, Seok HY, Callis TE, Thomson JM, Chen JF, Newman M, Rojas M, Hammond SM, Wang DZ (2007) Expression of microRNAs is dynamically regulated during cardiomyocyte hypertrophy. J Mol Cell Cardiol 42:1137-1141
43. Thum T, Galuppo P, Wolf C, Fiedler J, Kneitz S, van Laake LW, Doevendans PA, Mummery CL, Borlak J, Haverich A, Gross C, Engelhardt S, Ertl G, Bauersachs J (2007) MicroRNAs in the human heart: a clue to fetal gene reprogramming in heart failure. Circulation 116:258-267
44. Akar FG, Tomaselli GF (2005) Ion channels as novel therapeutic targets in heart failure. Ann Med 37:44-54
45. Day CP, McComb JM, Campbell RWF (1990) QT dispersion: an indication of arrhythmia risk in patients with long QT intervals. Br Heart J 63:342-344
46. Roden DM, Yang T (2005) Protecting the heart against arrhythmias: potassium current physiology and repolarization reserve. Circulation 112:1376-1378
47. Ks contributes to the longer action potential of the M cell. Circ Res 76:351-365
48. Verduyn SC, Vos MA, van der Zande J, van der Hulst FF, Wellens HJ (1997) Role of interventricular dispersion of repolarization in acquired torsade-de-pointes arrhythmias: Reversal by magnesium. Cardiovasc Res 34:453-463
49. Szentadrassy N, Banyasz T, Biro T, Szabo G, Toth BI, Magyar J, Lazar J, Varro A, Kovacs L, Nanasi PP (2005) Apico-basal inhomogeneity in distribution of ion channels in canine and human ventricular myocardium. Cardiovasc Res 65:851-860
50. Ks in human ventricular muscle. Circulation 112:1392-1399
51. Ks-encoding genes and potential implications in regional heterogeneity of their expressions. J Cell Physiol 212:358-367
52. Cardoso C, Salles G, Bloch K, Deccache W, Siqueira-Filho AG (2001) Clinical determinants of increased QT dispersion in patients with diabetes mellitus. Int J Cardiol 79:253-262
53. Veglio M, Chinaglia A, Cavallo-Perin P (2004) QT interval, cardiovascular risk factors and risk of death in diabetes. J Endocrinol Invest 27:175-181
54. + channel function as a mechanism for insulin treatment of the abnormal QT prolongation and the associated arrhythmias in diabetic rabbits. Am J Physiol 291:1446-1455
55. + channel expression contributing to QT prolongation in diabetic hearts. J Biol Chem 282:12363-12367
56. Ghuran AV, Camm AJ (2001) Ischaemic heart disease presenting as arrhythmias. Br Med Bull 59:193-210
57. Clements-Jewery H, Hearse DJ, Curtis MJ (2005) Phase 2 ventricular arrhythmias in acute myocardial infarction: a neglected target for therapeutic antiarrhythmic drug development and for safety pharmacology evaluation. Br J Pharmacol 145:551-564
58. Yang B, Lin H, Xiao J, Luo X, Li B, Lu Y, Wang H, Wang Z (2007) The muscle-specific microRNA miR-1 causes cardiac arrhythmias by targeting GJA1 and KCNJ2 genes. Nat Med 13:486-491
59. Jongsma HJ, Wilders R (2000) Gap junctions in cardiovascular disease. Circ Res 86:1193-1197
60. + channels (Kir2.1 or Kir2.2) abolishes protection by ischemic preconditioning in rabbit ventricular cardiomyocytes. Circ Res 95:325-332
61. Wang Z, Yue L, White M, Pelletier G, Nattel S (1998) Differential expression of inward rectifier potassium channel mRNA in human atrium versus ventricle and in normal versus failing hearts. Circulation 98:2422-2428
62. + current in rabbit and human hearts. Circ Res 84:551-561
63. Costantini DL, Arruda EP, Agarwal P, Kim K-H, Zhu Y, Lebel M, Cheng CW, Park CY, Pierce S, Guerchicoff A, Pollevick GD, Chan TY, Kabir MG, Cheng SH, Husain M, Antzelevitch C, Srivastava D, Gross GJ, Hui CC, Backx PH, Bruneau BG (2005) The homeodomain transcription factor Irx5 establishes the mouse cardiac ventricular repolarization gradient. Cell 123:347-358
64. Suárez Y, Fernández-Hernando C, Pober JS, Sessa WC (2007) Dicer dependent microRNAs regulate gene expression and functions in human endothelial cells. Circ Res 100:1164-1173
65. Kuehbacher A, Urbich C, Zeiher AM, Dimmeler S (2007) Role of Dicer and Drosha for endothelial microRNA expression and angiogenesis. Circ Res 101:59-68
66. \Xu C, Lu Y, Lin H, Xiao, J, Wang H, Luo X, Li B, Yang B, Wang Z (2007) The muscle-specific microRNAs miR-1 and miR-133 produce opposing effects on apoptosis via targeting HSP60/HSP70 and caspase-9 in cardiomyocytes. J Cell Sci 120:3045-3052
67. Kirchhoff SR, Gupta S, Knowlton AA (2002) Cytosolic HSP60, apoptosis, and myocardial injury. Circulation 105:2899-2904
68. Marber MS, Mestril R, Chi SH, Sayen MR (1995) Overexpression of the rat inducible 70 kDa heat shock protein in a transgenic mouse increases the resistance of the heart to ischemic injury. J Clin Invest 95:1446-1456
69. \Han Y, Chen YS, Liu Z, Bodyak N, Rigor D, Bisping E, Pu WT, Kang PM (2006) Overexpression of HAX-1 protects cardiac myocytes from apoptosis through caspase-9 inhibition. Circ Res 99:415-423
70. Weiler J, Hunziker J, Hall J (2006) Anti-miRNA oligonucleotides (AMOs): ammunition to target miRNAs implicated in human disease? Gene Ther 13:496-502
71. Hammond SM (2006) MicroRNA therapeutics: a new niche for antisense nucleic acids. TiMM 12:99-101
72. Krutzfeldt J, Rajewsky N, Braich R, Rajeev KG, Tuschl T, Manoharan M, Stoffel M (2005) Silencing of microRNAs in vivo with 'antagomirs'. Nature 438:685-689
73. Ebert MS, Neilson JR, Sharp PA (2007) MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells. Nat Methods 4:721-726
74. Xiao J, Yang B, Lin H, Lu Y, Luo X, Wang Z (2007) Novel approaches for gene-specific interference via manipulating actions of microRNAs: examination on the pacemaker channel genes HCN2 and HCN4. J Cell Physiol 212:285-292
75. f and the biological pacemaker. Pharmacol Res 53:407-415
76. Choi WY, Giraldez AJ, Schier AF (2007) Target protectors reveal dampening and balancing of Nodal agonist and antagonist by miR-430. Science 318:271-274